Keratinocytic Vascular Endothelial Growth Factor as a Novel Biomarker for Pathological Skin Condition
Open Access
- 31 January 2015
- journal article
- review article
- Published by The Korean Society of Applied Pharmacology in Biomolecules & Therapeutics
- Vol. 23 (1), 12-18
- https://doi.org/10.4062/biomolther.2014.102
Abstract
Skin is an emerging target tissue in pharmaceutical and cosmetic science. Safety assessment for dermal toxicity is a critical step for development of topically applicable pharmaceutical agents and ingredients in cosmetics. Urgent needs exist to set up toxicity testing methods for dermal safety, and identification of novel biomarkers for pathological cutaneous alteration is highly required. Here we will discuss if vascular endothelial growth factor (VEGF) has a potential as a biomarker for dermal impairment. Experimental and clinical evidences for induction of keratinocytic VEGF under pathological conditions will be reviewed.Keywords
Funding Information
- Ministry of Food and Drug Safety(MFDS) (13172MFDS987)
This publication has 87 references indexed in Scilit:
- Keratinocytes under Fire of Proinflammatory Cytokines: Bona Fide Innate Immune Cells Involved in the Physiopathology of Chronic Atopic Dermatitis and PsoriasisJournal of Allergy, 2012
- Differential Activation of Signaling Pathways by UVA and UVB Radiation in Normal Human Epidermal Keratinocytes†Photochemistry and Photobiology, 2012
- Epidermal barrier dysfunction and cutaneous sensitization in atopic diseasesJCI Insight, 2012
- The Cutaneous Vascular System in Chronic Skin InflammationJournal of Investigative Dermatology Symposium Proceedings, 2011
- Vascular Endothelial Growth Factor: Much More than an Angiogenesis FactorMolecular Biology of the Cell, 2010
- Systemic anti-VEGF treatment strongly reduces skin inflammation in a mouse model of psoriasisProceedings of the National Academy of Sciences of the United States of America, 2009
- Cancer-related inflammationNature, 2008
- HIF-1α regulates epithelial inflammation by cell autonomous NFκB activation and paracrine stromal remodelingBlood, 2008
- VEGF receptor signalling ? in control of vascular functionNature Reviews Molecular Cell Biology, 2006
- The biology of VEGF and its receptorsNature Medicine, 2003